The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.

No retinopathy was present in 36%, mild nonproliferative diabetic retinopathy in 53%, moderate to severe nonproliferative diabetic retinopathy in 9%, and proliferative diabetic retinopathy in 2% ...

Diabetes. 2005;54(7):2188-2197.

Incident nonproliferative diabetic retinopathy was defined using diagnostic codes for mild, moderate, or severe disease. The diabetic retinopathy progression outcome was defined as a composite of ...

The risk for nonproliferative diabetic retinopathy progression was similar for empagliflozin vs DPP4i therapy. (HealthDay News) — Empagliflozin initiation is not associated with incident ...